Home | Welcome to Contract Pharma   
Last Updated Sunday, April 26 2015

Print

Breaking News

Gil Roth
July 21, 2011
Economic development vet to add input for strategy and implementation  Read More »
July 21, 2011
Group sales were stable in local currencies, up 2%.  Read More »
July 21, 2011
Revenue growth helps offset generic competition; restructuring costs hit earnings.  Read More »
July 21, 2011
BioScience revenues top $1.6 billion, driven by Gammagard demand.  Read More »
July 21, 2011
Soliris sales jump 48% to $185.7 million.  Read More »
Gil Roth
July 20, 2011
Costs will grow in advance of Pfizer partnership revenues  Read More »
Gil Roth
July 20, 2011
Five additions expand operational and senior management team  Read More »
July 20, 2011
$56 mil. acquisition locks in ion channel development partner  Read More »
July 20, 2011
Collaboration covers Victrelis in combination therapy  Read More »
July 20, 2011
Humira sales continue to drive pharma growth  Read More »
Gil Roth
July 19, 2011
Clinical unit recognized for participation in Quality activities  Read More »
Gil Roth
July 19, 2011
Move adds natural products library to drug discovery offerings  Read More »
Gil Roth
July 19, 2011
Scott to lead bioanalytical labs in U.S., Canada  Read More »
Gil Roth
July 19, 2011
Favorable currency changes boost revenues, but earning suffer with Cordis charges  Read More »
Gil Roth
July 19, 2011
Alcon, new products, generics and currency flux help boost sales  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On